People in brief | Abbott, Unilever, CHPA, Teva
15 November 2019
Abbott, Unilever, the US Consumer Healthcare Products Association (CHPA) and Teva Pharmaceutical have all announced people changes.
Industry News - Tag: CHPA
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Industry in brief | CBD, Probi, Thornton & Ross
9 October 2019
The US dietary supplement industry wants rapid action on cannabidiol (CBD) products, Probi has revised its 2019 sales forecast and Thornton & Ross is expanding its capacity.
People in brief | BioGaia, EMA, CHPA, Bayer
4 October 2019
BioGaia, the European Medicines Agency (EMA), the US Consumer Healthcare Products Association (CHPA) and Bayer have all announced people changes.
US CHPA adds director of health policy to team
14 August 2019
The US Consumer Healthcare Products Association (CHPA) has expanded its team with a director of health policy who will focus on promoting OTC values to health insurers, health providers and employers.
Regulators must move quickly on CBD regulation
Premium
7 June 2019
The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is li...
US FDA considers ways of regulating CBD
9 April 2019
The US Food and Drug Administration (FDA) is holding a public hearing on potential ways of regulating products containing cannabis and cannabis-derived compounds including cannabidiol (CBD).
People in brief | Sandoz, Allergan, US CHPA
22 March 2019
Sandoz and Allergan have announced people changes while the US Consumer Healthcare Products Association (CHPA) has honoured a longtime industry leader.
US to revamp dietary supplements regulation
14 February 2019
The Food and Drug Administration (FDA) plans to strengthen the regulation of dietary supplements in the US. The regulatory agency describes the move as "one of the most significant modernisations of dietary supplements regulation and oversight in more than 25 years".
US FDA paves the way for more OTC switches
18 July 2018
Draft guidance from the US Food and Drug Administration (FDA) paves the way for companies switching medicines from prescription to non-prescription status to make use of new types of labelling and digital health technologies.